200 likes | 327 Views
ICAP-supported HIV care and treatment services in Tanzania. Number of ICAP-supported facilities by USG-funded activity, Tanzania. Source: ICAP Tanzania Site Census, August 2007.
E N D
Number of ICAP-supported facilities by USG-funded activity, Tanzania Source: ICAP Tanzania Site Census, August 2007
Cumulative and current enrollment in HIV care (pre-ART and ART) & ART care at ICAP-supported facilities, July 2004 - June 2007 HIV care (pre-ART and ART) ART care ART patients retained* Source: ICAP URS, July 2007 *Includes ART patients who are not known to have died, transferred or lost to follow-up.
Cumulative pediatric enrollment in ART care at ICAP-supported facilities, January 2006 - June 2007 HIV care (pre-ART and ART) ART care ART patients retained* Source: ICAP URS, July 2007 *Includes ART patients who are not known to have died, transferred or lost to follow-up.
Number of ICAP-supported care and treatment facilities reporting, July 2004 – June 2007 Source: ICAP URS, July 2007
Pediatric (<15) enrollment in HIV care (% of total patients) at ICAP-supported facilities as of June 2007 (n=24) Source: ICAP URS, July 2007
Actual versus targeted HIV care enrollment to February 2008 at ICAP-supported care and treatment facilities as of June 2007 Source: ICAP Tanzania Site Census, August 2007
Cumulative enrollment in pre-ART and ART care by age and sex at ICAP-supported facilities as of June 2007 (Total in care = 24,716) n=11,657 n=13,059 n=24,716 Source: ICAP URS, July 2007
Cumulative pediatric (<15) enrollment in pre-ART and ART care by age at ICAP-supported facilities as of June 2007 (Total in care = 2,205) n=1,071 n=1,134 n=2,205 Source: ICAP URS, July 2007
ART regimens for patients currently enrolled at ICAP-supported facilities by age, April-June 2007 Source: ICAP Tanzania URS, July 2007
Percentage of patients with CD4 counts at baseline, 6 and 12 months after ART initiation over time at ICAP-supported facilities to June 2007* Number of patients at baseline n=n/a n=495 n=601 n=544 Source: ICAP URS, July 2007 *CD4 data are for a subset of patients initiating ART
Average median CD4 count (cells/µL) after 6 and12 months of ART over time at ICAP-supported sites to June 2007* Number of patients at baseline n=n/a n=495 n=601 n=544 Source: ICAP URS, July 2007 *CD4 data are for a subset of patients initiating ART
Proportion discontinuing ART at ICAP-supported facilities as of June 2007* LTF55% 111 per 1,000 person-years 115 per 1,000 person-years Dead 37% 19 per 1,000 person-years Stopped ART 7% Source: ICAP URS, July 2007 *Does not include patients who transferred out
Program and Facility Characteristics Tracking System (P-FaCTS)
On-site services at ICAP-supported care and treatment facilities*,Tanzania (n=17 of 26) 2 service <1% 4 services <1% 3 services <1% n=16/17 n=16/17 n=16/17 n=16/17 n=17/17 1 service 6% 5 services 94% Source ICAP Tanzania P-FaCTS, January 2007 *Includes data from 17 of 26 facilities (65%) for which a P-FaCTS assessment has been completed
Patient support services at ICAP-supported care and treatment facilities*,Tanzania (n=17 of 26) 5 services <1% n=17/17 n=5/17 n=0/17 n=1/17 n=0/17 4 services <1% 3 services <1% 2 services 35% 1 service 65% Source ICAP Tanzania P-FaCTS, January 2007 *Includes data from 17 of 26 facilities (65%) for which a P-FaCTS assessment has been completed
Median number of staff per 1000 patients on ART at ICAP-supported care and treatment facilities in Tanzania by cadre* (n=17 of 26) Source ICAP Tanzania P-FaCTS, January 2007 *Includes data from 17 of 26 facilities (65%) for which a P-FaCTS assessment has been completed
HIV-infected pregnant women receiving ART prophylaxis* in ANC at ICAP-supported PMTCT facilities, April-June 2007 *Maternal ART prophylaxis includes: sd-NVP, AZT/sd-NVP, AZT/sd-NVP + 3TC/AZT tail, and HAART at 34 weeks
Women and infants receiving ART prophylaxis* in maternity at ICAP-supported PMTCT facilities, April-June 2007 *Maternal ART prophylaxis includes: sd-NVP, AZT/sd-NVP, AZT/sd-NVP + 3TC/AZT tail, and HAART at 34 weeks